Insider Shareholders with Direct Ownership of Acumen Pharmaceuticals, Inc. (ABOS)
This section provides a comprehensive overview of the insiders with direct ownership of Acumen Pharmaceuticals, Inc. (ABOS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Acumen Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Sands Capital Ventures Discovery Fund Iii, L.P.
> 10% Shareholder |
3,417,075 | 0 | 3,417,075 $4.75 Million | 1 |
Jul 06, 2021
Added 11.64%
|
|
Daniel Joseph O Connell
Chief Executive Officer |
741,676 | 75,607 | 667,488 $927,808 | 9 |
Jan 21, 2025
Reduced 1.86%
|
|
Matt Zuga
CFO & Chief Business Officer |
282,487 | 50,743 | 231,744 $322,124 | 9 |
Jan 23, 2025
Reduced 11.09%
|
|
John A Stalfort Iii
Director |
165,180 | 0 | 172,324 $239,530 | 1 |
Jul 06, 2021
Added 16.88%
|
|
Eric Siemers
Chief Medical Officer |
187,500 | 17,202 | 170,298 $236,714 | 6 |
Jan 21, 2025
Reduced 1.86%
|
|
Derek M Meisner
Chief Legal Officer & Corp Sec |
184,600 | 23,473 | 161,127 $223,966 | 6 |
Jan 21, 2025
Reduced 2.08%
|
|
Russell Barton
Chief Operating Officer |
149,500 | 13,383 | 136,117 $189,202 | 6 |
Jan 21, 2025
Reduced 2.1%
|
|
James J. Doherty
President and CDO |
62,600 | 0 | 62,600 $87,014 | 1 |
Jan 06, 2025
Added 50.0%
|
|
Amy Schacterle
Chief Regulatory Officer |
8,800 | 0 | 8,800 $12,232 | 1 |
Jan 06, 2025
Added 50.0%
|
|
Nathan B Fountain
Director |
6,250 | 0 | 6,250 $8,687 | 1 |
Jul 06, 2021
Added 50.0%
|
|
Jeffrey L. Ives
Director |
41,949 | 41,949 | 0 $0 | 2 |
Aug 17, 2023
Reduced 100.0%
|